Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female subjects greater than or equal to 18 years. Female subjects must be of non-child bearing potential.
Clinical diagnosis of type 2 diabetes together with stages 3a, 3b or 4 CKD, based on an eGFR of 25-59 mL/min/1.73m2.
Evidence of persistent, overt albuminuria; defined as a UACR greater than or equal to 300 mg/g (greater than or equal to 33.9 mg/mmol) for greater than 3 months.
You may not be if
Subjects with CKD resulting from type 1 diabetes or non-diabetic CKD.
Subjects with poorly controlled diabetes mellitus, defined as HbA1C \>9%.
Subjects on combination ACE inhibitor/ARB therapy.
Clareo Health | A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
